Clinical Trial Update: Tislelizumab and Radiotherapy for Recurrent Cervical Cancer [Phase 2]

View source ↗

Summary

A phase 2 clinical trial evaluating tislelizumab in combination with radiotherapy for recurrent/metastatic cervical cancer; current status and outcomes are not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Carcinoma

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Lei Li | Conditions: Recurrent Cervical Carcinoma, Metastatic Cervical Carcinoma | Phase 2 | Status: UNKNOWN